William Plovanic
Stock Analyst at Canaccord Genuity
(3.28)
# 1,003
Out of 4,712 analysts
138
Total ratings
45.08%
Success rate
2.45%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $85 → $92 | $83.47 | +10.22% | 2 | Dec 9, 2024 | |
| PODD Insulet | Maintains: Buy | $269 → $304 | $263.23 | +15.49% | 3 | Dec 9, 2024 | |
| NVRO Nevro | Maintains: Hold | $7 → $4 | $3.97 | +0.76% | 11 | Dec 9, 2024 | |
| IRTC iRhythm Technologies | Maintains: Buy | $125 → $152 | $89.37 | +70.08% | 9 | Dec 9, 2024 | |
| DXCM DexCom | Maintains: Buy | $89 → $99 | $80.24 | +23.38% | 4 | Dec 9, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $17 → $22 | $12.90 | +70.54% | 6 | Dec 9, 2024 | |
| CBLL CeriBell | Maintains: Buy | $31 → $33 | $26.98 | +22.31% | 3 | Dec 9, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $98 → $101 | $91.07 | +10.90% | 9 | Dec 9, 2024 | |
| ATRC AtriCure | Maintains: Buy | $53 → $61 | $30.50 | +100.00% | 9 | Dec 9, 2024 | |
| EW Edwards Lifesciences | Maintains: Hold | $63 → $68 | $75.38 | -9.79% | 24 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $104 | $63.90 | +62.75% | 4 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $4.75 | +131.58% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $56 | $37.00 | +51.35% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $10.68 | +40.45% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $74 | $53.65 | +37.93% | 14 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $12 | $8.69 | +38.09% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $120 → $115 | $107.30 | +7.18% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $3 | $1.46 | +105.48% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $240.36 | +18.16% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $9.23 | +170.86% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $6.16 | +94.81% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $98.08 | -28.63% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $24.97 | +92.23% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $8.15 | +169.94% | 3 | Jul 25, 2023 |
Globus Medical
Dec 9, 2024
Maintains: Buy
Price Target: $85 → $92
Current: $83.47
Upside: +10.22%
Insulet
Dec 9, 2024
Maintains: Buy
Price Target: $269 → $304
Current: $263.23
Upside: +15.49%
Nevro
Dec 9, 2024
Maintains: Hold
Price Target: $7 → $4
Current: $3.97
Upside: +0.76%
iRhythm Technologies
Dec 9, 2024
Maintains: Buy
Price Target: $125 → $152
Current: $89.37
Upside: +70.08%
DexCom
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $99
Current: $80.24
Upside: +23.38%
CVRx, Inc.
Dec 9, 2024
Maintains: Buy
Price Target: $17 → $22
Current: $12.90
Upside: +70.54%
CeriBell
Dec 9, 2024
Maintains: Buy
Price Target: $31 → $33
Current: $26.98
Upside: +22.31%
Boston Scientific
Dec 9, 2024
Maintains: Buy
Price Target: $98 → $101
Current: $91.07
Upside: +10.90%
AtriCure
Dec 9, 2024
Maintains: Buy
Price Target: $53 → $61
Current: $30.50
Upside: +100.00%
Edwards Lifesciences
Dec 5, 2024
Maintains: Hold
Price Target: $63 → $68
Current: $75.38
Upside: -9.79%
Nov 20, 2024
Maintains: Buy
Price Target: $109 → $104
Current: $63.90
Upside: +62.75%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $11
Current: $4.75
Upside: +131.58%
Nov 7, 2024
Maintains: Buy
Price Target: $57 → $56
Current: $37.00
Upside: +51.35%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $10.68
Upside: +40.45%
Oct 29, 2024
Maintains: Buy
Price Target: $71 → $74
Current: $53.65
Upside: +37.93%
Oct 4, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $8.69
Upside: +38.09%
Sep 10, 2024
Maintains: Hold
Price Target: $120 → $115
Current: $107.30
Upside: +7.18%
Aug 13, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.46
Upside: +105.48%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $240.36
Upside: +18.16%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $9.23
Upside: +170.86%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $6.16
Upside: +94.81%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $98.08
Upside: -28.63%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $24.97
Upside: +92.23%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $8.15
Upside: +169.94%